[Catalytic Synthesis of Optically Active Polycyclic Heterocyclic Compounds]

Area of Science:

• Organic Chemistry
• Catalysis
• Drug Discovery

Background:

• Efficient synthesis of cyclic molecules is crucial for pharmaceutical sciences and drug development.
• Asymmetric synthesis of cyclic compounds, particularly via the Diels-Alder reaction of Danishefsky diene, remains a significant challenge.
• Previous methods lacked effective asymmetric variants for constructing specific enantiomers of cyclic skeletons.

Purpose of the Study:

• To develop novel chiral catalysts for asymmetric ring formation reactions.
• To achieve the first catalytic asymmetric Diels-Alder reaction using Danishefsky diene.
• To apply these catalysts for the synthesis of complex, biologically active molecules and natural products.

Main Methods:

• Development of new chiral lanthanide catalysts.
• Catalytic asymmetric Diels-Alder reactions utilizing modified Danishefsky diene.
• Application of catalysts to synthesize polycyclic compounds and biologically active molecules.
• Exploration of nickel and indium metal precursors for catalyst development.

Main Results:

• Successfully realized the catalytic asymmetric Diels-Alder reaction of Danishefsky diene for the first time.
• Synthesized optically active cyclic skeletons, including natural products, antibacterial, antimalarial compounds, and an anti-obesity drug lead.
• Developed novel catalysts with improved performance and air/room temperature stability.
• Extended catalyst utility to nickel and indium precursors for polycyclic skeleton construction.

Conclusions:

• The developed chiral lanthanide catalysts represent a significant advancement in asymmetric synthesis.
• This methodology enables efficient access to enantiomerically pure cyclic compounds vital for drug discovery.
• The catalysts offer practical advantages, including stability and broad applicability to various biologically relevant molecules.